Becton Dickinson

OverviewSuggest Edit

Becton, Dickinson and Company (BD) is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. It operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment offers medication delivery and management solutions, diabetes care products, and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products. The company serves healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.

TypePublic
Founded1897
HQFranklin Lakes, NJ, US
Websitebd.com
Employee Ratings3.9
Overall CultureA-

Latest Updates

Employees (est.) (Sept 2021)75,000(+5%)
Job Openings1,267
Revenue (FY, 2021)$20.2 B(+19%)
Share Price (May 2022)$256.5(+2%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Becton Dickinson

Simon D. Campion

Simon D. Campion

Executive Vice President and President, Interventional Segment
Christopher Delorefice

Christopher Delorefice

Executive Vice President and Chief Financial Officer
Tony Ezell

Tony Ezell

Executive Vice President, North America and Chief Marketing Officer
Jerry Flasz

Jerry Flasz

Executive Vice President, Global Services and Chief Information Officer
James Lim

James Lim

Executive Vice President and President, Greater Asia
Roland Goette

Roland Goette

Executive Vice President and President, Europe, Middle East and Africa (EMEA)
Show more

Becton Dickinson Office Locations

Becton Dickinson has offices in Franklin Lakes, Andover, Billerica, Broken Bow and in 84 other locations
Franklin Lakes, NJ, US (HQ)
Howe Buidling, 1 Becton Dr
Andover, MA, US
200 Bulfinch Dr
Billerica, MA, US
296 Concord Rd #280
Broken Bow, NE, US
150 S 1st Ave
Burlington, NC, US
780 Plantation Dr
Canaan, CT, US
7 Grace Way
Show all (93)

Becton Dickinson Financials and Metrics

Becton Dickinson Revenue

Embed Graph
View revenue for all periods
Becton Dickinson's revenue was reported to be $20.25 b in FY, 2021 which is a 18.3% increase from the previous period.
USD

Revenue (Q1, 2022)

5.0b

Gross profit (Q1, 2022)

2.4b

Gross profit margin (Q1, 2022), %

48.5%

Net income (Q1, 2022)

677.0m

EBIT (Q1, 2022)

815.0m

Market capitalization (27-May-2022)

73.1b

Closing stock price (27-May-2022)

256.5

Cash (31-Dec-2021)

1.9b

EV

88.6b
Becton Dickinson's current market capitalization is $73.1 b.
Annual
USDFY, 2019FY, 2020FY, 2021

Revenue

17.3b17.1b20.2b

Revenue growth, %

8%(1%)18%

Cost of goods sold

9.0b9.5b10.8b

Gross profit

8.3b7.6b9.4b
Quarterly
USDQ1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022

Revenue

4.2b4.3b3.9b5.3b4.9b4.9b5.0b

Cost of goods sold

2.2b2.5b2.2b2.6b2.7b2.7b2.6b

Gross profit

2.0b1.7b1.7b2.7b2.2b2.2b2.4b

Gross profit Margin, %

47%41%43%51%46%44%49%
Annual
USDFY, 2019FY, 2020FY, 2021

Cash

536.0m2.8b2.3b

Accounts Receivable

2.3b2.4b2.5b

Prepaid Expenses

1.1b891.0m1.1b

Inventories

2.6b2.7b2.9b
Quarterly
USDQ1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q1, 2022

Cash

560.0m2.4b2.9b3.2b3.7b1.9b

Accounts Receivable

2.1b2.2b2.0b2.4b2.1b2.2b

Prepaid Expenses

987.0m1.2b903.0m889.0m1.1b1.0b

Inventories

2.8b2.8b2.9b2.8b2.9b3.0b
Annual
USDFY, 2019FY, 2020FY, 2021

Net Income

1.2b874.0m2.1b

Depreciation and Amortization

2.3b2.2b2.3b

Inventories

(149.0m)(125.0m)(104.0m)

Accounts Payable

(470.0m)205.0m687.0m
Quarterly
USDQ1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

278.0m461.0m746.0m1.0b

Depreciation and Amortization

530.0m1.1b1.6b555.0m

Cash From Operating Activities

713.0m1.2b2.1b1.5b

Capital Expenditures

(173.0m)(395.0m)(597.0m)(246.0m)
USDFY, 2019

EV/EBIT

49.5 x

EV/CFO

26.2 x

EV/FCF

36.7 x

Revenue/Employee

246.7k

Debt/Equity

0.9 x

Debt/Assets

0.4 x

Financial Leverage

2.5 x

P/E Ratio

64.2
Show all financial metrics

Becton Dickinson Operating Metrics

FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020FY, 2021

Facilities

255289380362323

Facility Space, sq. ft.

19.8 m20.46 m24.66 m25.3 m25.21 m

Facilities (Owned)

607189

Facilities (Leased)

195218291325

Becton Dickinson Acquisitions / Subsidiaries

Company NameDateDeal Size
CytognosJanuary 31, 2022
Scanwell Health Inc.December 20, 2021
Tissuemed, Ltd.December 08, 2021
Venclose, Inc.December 01, 2021
Tepha, Inc.July 26, 2021
Velano VascularJuly 19, 2021
GSL SolutionsMarch 03, 2021
CubexNovember 12, 2020
Straub Medical AGMay 18, 2020
NAT Diagnostics, Inc.May 08, 2020
Show more

Becton Dickinson Revenue Breakdown

Embed Graph

Becton Dickinson revenue breakdown by business segment: 46.8% from Medical, 20.9% from Interventional and 32.3% from Life Sciences

Becton Dickinson revenue breakdown by geographic segment: 23.5% from EMEA, 16.2% from Greater Asia, 54.2% from United States and 6.2% from Other

Becton Dickinson Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

Becton Dickinson Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

60-79

out of 100

CSRHub logo

Becton Dickinson Online and Social Media Presence

Embed Graph

Becton Dickinson Company Culture

  • Overall Culture

    A-

    75/100

  • CEO Rating

    A+

    81/100

  • Compensation

    B+

    75/100

  • Diversity

    B

    71/100

Learn more on Comparably

Becton Dickinson News and Updates

BD and Mitsubishi Gas Chemical have signed a letter of intent (LOI) to discuss a partnership agreement to explore new ways to advance biologic drug delivery

Companies to work together with the aim of optimizing advanced technologies for use in prefillable syringes

Worldwide COVID-19 Testing Industry Report 2022 - Featuring Abbott Laboratories, Becton Dickinson, bioMerieux and Danaher Among Others

DUBLIN, May 16, 2022 /PRNewswire/ -- The "COVID-19 Testing Market Update, 2022" report has been added to ResearchAndMarkets.com's offering. This report, COVID-19 Testing Market Update, 2022, provides market sizing and estimates for COVID-19 tests with some discussion of market impacts of...

Babson, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings

Expanded Collaboration Agreement to Make Less Invasive Blood Sample Collection More Convenient and Patient Centered AUSTIN, Texas and FRANKLIN LAKES, N.J., May 11, 2022 /PRNewswire/ -- Babson Diagnostics, a science-first, health care technology company, and BD (Becton, Dickinson and...

BD Announces Inaugural Members of Scientific Advisory Board

Scientific Advisory Board Will Review Company Innovation Pipeline and Advise on Emerging Trends in Health Care, Science and Technology FRANKLIN LAKES, N.J., May 2, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today...

BD Named to Forbes' 2022 List of Best Employers for Diversity

Demonstrates Progress in Advancing 2030+ ESG Goals FRANKLIN LAKES, N.J., April 26, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been recognized by Forbes as one of the top employers in the U.S....
Show more

Becton Dickinson Frequently Asked Questions

  • When was Becton Dickinson founded?

    Becton Dickinson was founded in 1897.

  • Who are Becton Dickinson key executives?

    Becton Dickinson's key executives are Simon D. Campion, Christopher Delorefice and Tony Ezell.

  • How many employees does Becton Dickinson have?

    Becton Dickinson has 75,000 employees.

  • What is Becton Dickinson revenue?

    Latest Becton Dickinson annual revenue is $20.2 b.

  • What is Becton Dickinson revenue per employee?

    Latest Becton Dickinson revenue per employee is $270 k.

  • Who are Becton Dickinson competitors?

    Competitors of Becton Dickinson include B. Braun, Cardinal Health and 10X Genomics.

  • Where is Becton Dickinson headquarters?

    Becton Dickinson headquarters is located at Howe Buidling, 1 Becton Dr, Franklin Lakes.

  • Where are Becton Dickinson offices?

    Becton Dickinson has offices in Franklin Lakes, Andover, Billerica, Broken Bow and in 84 other locations.

  • How many offices does Becton Dickinson have?

    Becton Dickinson has 93 offices.